14 results
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Comparison of anti-diabetic ... risks, and therapy ... #pharmacology #pharmacotherapy ... #table #comparison ... endocrinology #treatment
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
management #algorithm #pharmacology ... #treatment #medications ... #table #pharmacotherapy ... #decisionaid #cardiology ... hematology #warfarin #dosing
PDE5 inhibitors are usually the drugs of first choice for erectile dysfunction.

PDE5 inhibitors enhance an erection that is
alpha blockers and ... #pharmacology #comparison ... #treatment #medications ... #dosing #drugs ... #table #pharmacotherapy
Estimated Medical Radiation Doses for 5 Year-Old Child

3-view ankle	0.0015 mSv	1/14th CXRs
2-view chest	0.02 mSv	1 CXRs
Anteroposterior and lateral
view chest 0.02 mSv ... Anteroposterior and ... #PatientInfo #Radiology ... #CT #Nuclear #Comparison ... #Table #Risks #
Potassium-Binding Agents to Treat Hyperkalemia
Sodium zirconium cyclosilicate (Lokelma):
 • Mechanism: Preferentially captures K in exchange for
sodium • Dosing ... calcium • Dosing ... sodium intake; risk ... #medications #pharmacology ... #table #comparison
Perioperative Management of DOACs
Problem:
 ✖ Each year approximately 250,000 patients on chronic anticoagulation in North America
clearance (calculated using ... interruption per treatment ... table ... patient-specific and ... #pharmacology #
Radiation Dose to Adults from Common Imaging Examinations
ABDOMINAL REGION
 - Computed Tomography (CT) — Abdomen and
(CT) — Abdomen and ... - Extremity (hand ... #PatientInfo #Radiology ... #CT #Nuclear #Comparison ... #Table #Risks #
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Indication: Reduce risk ... Eosinophils < 100 Dosing ... : 250 mcg tablet ... recommendations for the treatment ... #Indications #Pharmacology
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
Risk Factors and ... Delivery • Stable ... Risk of recurrence ... diagnosis #management #cardiology ... #treatment
Clinically Significant Cardiovascular Drug-Drug Interactions With OTC Supplements and Herbal Products
Angiotensin-Converting Enzyme Inhibitors (ACEIs)
 • Night-blooming
Increases bleeding risk ... increased bleed risk ... Bilberry, Danshen, Dong ... supplementals #herbal #pharmacology ... #DDI #table #cardiology